Atlas Trials

A Prospective Longitudinal Study of Fecal Microbiome and Calprotectin to Predict Relapse in Patients With IBD

Clinical trial NCT04079335 · UNKNOWN

Trial details

NCT number
NCT04079335
Sponsor
Chinese University of Hong Kong
Status
UNKNOWN
Study type
OBSERVATIONAL
Inflammatory Bowel DiseasesUlcerative ColitisCrohn Disease
Start date
2019-01-28
Primary completion
2021-01-28
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.